Sponsor

2014/06/20

Nature Reviews Cardiology - Table of Contents alert Volume 11 Issue 7

If you are unable to see the message below, click here to view.

Nature Reviews CardiologyWorld Heart Federation
 
TABLE OF CONTENTS
 
July 2014 Volume 11 Number 7

Nature Reviews Cardiology cover
Impact Factor 10.400 *
In this issue
Research Highlights
News and Views
Reviews
Perspectives

Also this month
 Featured article:
Clinical classification of plaque morphology in coronary disease
Fumiyuki Otsuka, Michael Joner, Francesco Prati, Renu Virmani & Jagat Narula




Subscribe
 
Facebook
 
RSS
 
Recommend to library
 
Twitter
 
Advertisement
Nature Reviews Call for Cover Images!

Wanted - an eye-catching image per journal to feature on all 12 covers of the 2015 issues of the clinical Nature Reviews titles. We are offering the opportunity for one person's image to appear on each cover for a whole year! PLUS we'll send you a print of the cover as a thank you. 

Visit for more information 
 
RESEARCH HIGHLIGHTS

Top

Interventional cardiology: COMFORTABLE biodegradable stents in a new CENTURY?
Published online: 10 June 2014
p371 | doi:10.1038/nrcardio.2014.81

PDF


Arrhythmias: MINERVA trial results reported
Published online: 13 May 2014
p372 | doi:10.1038/nrcardio.2014.68

PDF


Coronary artery disease: Long-term superiority of CABG surgery for three-vessel disease confirmed
Published online: 10 June 2014
p372 | doi:10.1038/nrcardio.2014.82

PDF


Interventional cardiology: Sex-specific outcomes in PVI for PAD
Published online: 13 May 2014
p373 | doi:10.1038/nrcardio.2014.69

PDF


Prevention: Relating risk factor reduction to disease risk on a global level
Published online: 20 May 2014
p373 | doi:10.1038/nrcardio.2014.72

PDF


Arrhythmias: New PACES/HRS consensus statements
Published online: 27 May 2014
p373 | doi:10.1038/nrcardio.2014.76

PDF


Cardiac resuscitation: The 'smoker's paradox' after in-hospital cardiac arrest
Published online: 20 May 2014
p374 | doi:10.1038/nrcardio.2014.73

PDF


Device therapy: CRT effective in elderly patients with heart failure
Published online: 03 June 2014
p374 | doi:10.1038/nrcardio.2014.78

PDF


Cardiology
JOBS of the week
More Science jobs from
Cardiology
EVENT
2014 Cardiometabolic Health Congress
22.10.14
Boston, USA
More science events from
 
NEWS AND VIEWS

Top
Hypertension: How should data from SYMPLICITY HTN-3 be interpreted?
Roland E. Schmieder
Published online: 20 May 2014
p375 | doi:10.1038/nrcardio.2014.70
The SYMPLICITY HTN-3 trial demonstrated unexpectedly large and small blood pressure reductions in the control and renal denervation groups, respectively. Although this study was well designed, it had several weaknesses and the results are inconclusive, with the exception of the positive signal for renal denervation in non-African-American individuals.
Full Text | PDF


Pharmacotherapy: Colchicine for recurrent pericarditis—what's new in CORP-2?
Faisal F. Syed & Bongani M. Mayosi
Published online: 27 May 2014
p376 | doi:10.1038/nrcardio.2014.71
In the CORP-2 trial, patients with multiple recurrences of idiopathic or autoimmune pericarditis were randomly assigned to receive colchicine or placebo, in addition to standard anti-inflammatory therapy. After 6 months, colchicine significantly reduced recurrent pericarditis rates. Are we moving closer to a reliable treatment for this common disease?
Full Text | PDF



 
REVIEWS

Top
Clinical classification of plaque morphology in coronary disease
Fumiyuki Otsuka, Michael Joner, Francesco Prati, Renu Virmani & Jagat Narula
Published online: 29 April 2014
p379 | doi:10.1038/nrcardio.2014.62
In this Review, Otsuka et al. describe how optical coherence tomography (OCT)—an intravascular imaging modality with high resolution—can be used to define various stages of plaque progression. The authors also highlight how OCT might be used in the identification of high-risk plaques vulnerable to rupture in patients with coronary disease, to enable pre-emptive interventional treatment, and how OCT might be used in the management of acute coronary syndromes.
Abstract | Full Text | PDF


Comprehensive plaque assessment by coronary CT angiography
Pál Maurovich-Horvat, Maros Ferencik, Szilard Voros, Béla Merkely & Udo Hoffmann
Published online: 22 April 2014
p390 | doi:10.1038/nrcardio.2014.60
Catastrophic acute coronary events are often the result of ruptured atherosclerotic plaques and subsequent luminal thrombosis. Preventing such an event seems to be the only effective strategy to reduce mortality and morbidity of coronary artery disease. This Review highlights how computed tomography angiography might be combined with fluid dynamic assessment to identify rupture-prone plaques in patients with coronary artery disease.
Abstract | Full Text | PDF | Supplementary information


Natriuretic peptides in cardiometabolic regulation and disease
Nora E. Zois, Emil D. Bartels, Ingrid Hunter, Birgitte S. Kousholt, Lisbeth H. Olsen & Jens P. Goetze
Published online: 13 May 2014
p403 | doi:10.1038/nrcardio.2014.64
Dysregulation of the natriuretic peptide system has been associated with several life-style related metabolic and cardiovascular disorders, including obesity, type 2 diabetes mellitus, hypertension, atherosclerosis, thrombosis, and myocardial ischaemia, implying biological effects beyond pressure-volume homeostasis. In this Review, Zois et al. discuss the role of the various natriuretic peptides in the pathophysiology of these cardiometabolic conditions.
Abstract | Full Text | PDF


Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets
Fan Jiang, Jianmin Yang, Yongtao Zhang, Mei Dong, Shuangxi Wang, Qunye Zhang, Fang Fang Liu, Kai Zhang & Cheng Zhang
Published online: 29 April 2014
p413 | doi:10.1038/nrcardio.2014.59
Angiotensin-converting enzyme 2, and its product angiotensin 1-7, are thought to have counteracting effects against the adverse actions of the better-known members of the renin-angiotensin system and might, therefore, be useful therapeutic targets in patients with cardiovascular disease. Professor Jiang and colleagues review the evidence for the potential roles of these proteins in various cardiovascular conditions, including hypertension, atherosclerosis, myocardial remodelling, heart failure, ischaemic stroke, and diabetes.
Abstract | Full Text | PDF



 
PERSPECTIVES

Top
OPINION
A role for pericytes in coronary no-reflow
Fergus M. O'Farrell & David Attwell
Published online: 29 April 2014
p427 | doi:10.1038/nrcardio.2014.58
Coronary 'no-reflow' is a substantial clinical problem, even after successful percutaneous coronary intervention for myocardial infarction. In this Perspectives, article, O'Farrell and Attwell describe the similarities between this phenomenon and no-reflow in the brain after ischaemic stroke, and propose that pericytes contribute to the underlying pathophysiology in both situations. Cardiac pericytes might, therefore, be a novel therapeutic target for coronary no-reflow.
Abstract | Full Text | PDF


Advertisement
Scientific Reports is accepting submissions in the clinical sciences

Entirely open access, and hosted on nature.com, Scientific Reports publishes technically sound original research papers across the natural and clinical sciences. The scope of the journal has been broadened to include all fields of medical research. 

nature.com/scientificreports 
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events
*Journal Citation Reports, Thomson, 2012. Nature Reviews Cardiology was previously published as Nature Clinical Practice Cardiovascular Medicine.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our feedback department

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

No comments:

Post a Comment

Keep a civil tongue.

Label Cloud

Technology (1464) News (793) Military (646) Microsoft (542) Business (487) Software (394) Developer (382) Music (360) Books (357) Audio (316) Government (308) Security (300) Love (262) Apple (242) Storage (236) Dungeons and Dragons (228) Funny (209) Google (194) Cooking (187) Yahoo (186) Mobile (179) Adobe (177) Wishlist (159) AMD (155) Education (151) Drugs (145) Astrology (139) Local (137) Art (134) Investing (127) Shopping (124) Hardware (120) Movies (119) Sports (109) Neatorama (94) Blogger (93) Christian (67) Mozilla (61) Dictionary (59) Science (59) Entertainment (50) Jewelry (50) Pharmacy (50) Weather (48) Video Games (44) Television (36) VoIP (25) meta (23) Holidays (14)

Popular Posts (Last 7 Days)